Chronic Lymphocytic Leukemia

$Acalabrutinib Demonstrates Favorable Safety and Efficacy in Relapsed/Refractory CLL$

Videos

Acalabrutinib Demonstrates Favorable Safety and Efficacy in Relapsed/Refractory CLL

06/17/2020

Paolo Ghia, MD, PhD, discusses the results from the ASCEND study, which compared acalabrutinib monotherapy to physician’s choice of therapy in patients with relapsed or refractory CLL.

Paolo Ghia, MD, PhD, discusses...

06/17/2020

Oncology

News

Zanubrutinib Yields High Overall Response Rate in Patients With CLL/SLL

12/09/2019

According to updated data presented at ASH 2019, the next-generation BTK inhibitor zanubrutinib yields a high overall and durable response rate in patients with CLL/SLL.

According to updated data...

12/09/2019

Oncology

Videos

Novel Agents for Treating Older Patients With CLL

11/13/2019

Jennifer Woyach, MD, discusses treatment options for older patients with CLL and why treating older patients differs from treating younger patients.

Jennifer Woyach, MD, discusses...

11/13/2019

Oncology

Videos

Managing Venetoclax Resistance in CLL

11/12/2019

Matthew S. Davids, MD, MMSc, discusses venetoclax resistance in CLL and how to manage patients resistant to the drug.

Matthew S. Davids, MD, MMSc,...

11/12/2019

Oncology

Videos

Treating CLL That Progress With BTK Inhibitor Therapy

11/12/2019

Richard Furman, MD, explains how best to control CLL patients who progress on BTK inhibitor therapy.

Richard Furman, MD, explains how...

11/12/2019

Oncology

Podcasts

Ibrutinib Demonstrates Long-Term Efficacy and Tolerability in Relapsed/Refractory CLL

09/14/2019

Paul Barr, MD, shares 6-year follow-up data from patients with CLL or SLL treated with ibrutinib on the RESONATE study.

Paul Barr, MD, shares 6-year...

09/14/2019

Oncology

Videos

Jacqueline C. Barrientos, MD, MS, Explains the Rationale for Using Combination Therapies in CLL

06/18/2019

Jacqueline C. Barrientos, MD, MS, explains why combining therapies is beneficial for the treatment of patients with CLL.

Jacqueline C. Barrientos, MD,...

06/18/2019

Oncology

Videos

The Importance of Sequencing Monotherapy in CLL

04/06/2019

Jacqueline C. Barrientos, MD, MS, explains the importance of sequencing monotherapy in chronic lymphocytic leukemia.

Jacqueline C. Barrientos, MD,...

04/06/2019

Oncology

Videos

Richard R. Furman, MD, Discusses Ibrutinib Versus FCR for Patients With CLL

04/06/2019

Richard R. Furman, MD, discusses ibrutinib compared with the standard chemoimmunotherapeutic regimen of intravenous fludarabine, cyclophosphamide, and rituximab, for patients with CLL.

Richard R. Furman, MD, discusses...

04/06/2019

Oncology

Debates and Roundtables

Expert Roundtable: Lessons From ASH for Optimizing CLL Treatment

12/21/2018

Jeff Sharman, MD, Anthony Mato, MD, MSCE, and Chaitra Ujjani, MD, discussed the findings of an interim analysis from the prospective informCLL real-world registry and how to optimize CLL treatment in real-world practice.

Jeff Sharman, MD, Anthony Mato,...

12/21/2018

Oncology